10 Best AI Driven Biotech Stocks to Invest In
In this article, we will take a look at some of the best AI driven biotech stocks that are currently offering attractive upside potential.
Relay Therapeutics Inc. (RLAY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Commodore Capital Egen Atkinson And Michael Kramarz | 17,000,000 | $169,150,000 | 9.79% | |
| 2. | Casdin Capital Eli Casdin | 14,418,574 | $143,464,811 | +11% | 10.86% |
| 3. | Perceptive Advisors Joseph Edelman | 9,751,141 | $97,023,853 | +413% | 1.9% |
| 4. | Balyasny Asset Management Dmitry Balyasny | 3,039,179 | $30,239,831 | +45% | 0.04% |
| 5. | Spruce Street Capital Alex Rosen And Simon Basseyn | 2,984,125 | $29,692,044 | 7.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 25,000 | $500,000.00 | 403,082 | 2020-07-20 | Filing | |
| $20.00 | 25,000 | $500,000.00 | 1,021,952 | 2020-07-20 | Filing | |
| $20.00 | 25,000 | $500,000.00 | 25,000 | 2020-07-20 | Filing | |
| $20.00 | 25,000 | $500,000.00 | 25,000 | 2020-07-20 | Filing | |
| $20.00 | 10,000 | $200,000.00 | 10,000 | 2020-07-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.97 | 51,560 | $874,973.20 | 177,461 | 2026-06-22 | Filing | |
| $16.97 | 61,563 | $1,044,724.11 | 177,461 | 2026-06-22 | Filing | |
| $16.97 | 56,323 | $955,801.31 | 177,461 | 2026-06-22 | Filing | |
| $17.01 | 17,717 | $301,366.17 | 177,461 | 2026-06-22 | Filing | |
| $16.94 | 93,456 | $1,583,144.64 | 418,557 | 2026-06-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 27,904,963 | $277,654,382 | 3.59% | |
| 2. | 12,975,299 | $129,104,225 | 0% | |
| 3. | 7,795,242 | $77,562,658 | 1.85% | |
| 4. | 7,387,465 | $73,505,277 | 0% | |
| 5. | 6,233,545 | $62,023,773 | 0% |
News See All
10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen
On April 30, Bloomberg reported that Steve Cohen resigned as president of Point72 Asset Management, and Harry Schwefel was appointed co-CIO.
10 Stocks Reeling From Huge Losses
Zimmer Biomet fell to a new 13-year low on Tuesday, slashing 10.53 percent to close at $82.84 apiece despite posting a strong earnings performance in the first quarter, as investors were rattled by the...
JonesResearch Initiates Coverage of Relay Therapeutics (RLAY) With a Hold Rating
Relay Therapeutics, Inc. (NASDAQ:RLAY) is one of the best low priced biotech stocks to invest in. On April 13, JonesResearch initiated coverage of Relay Therapeutics, Inc.
8 Best Low Priced Biotech Stocks to Invest In
On April 16, Fundstrat’s Tom Lee appeared on CNBC's 'Closing Bell' to talk about what to expect from equity markets going forward.
10 Stocks With Easy 8-20% Gains
Ten stocks finished the last trading day of the week, clocking significant gains, defying a lackluster market performance, as investors took heart from a flurry of positive developments in the industry...
Oppenheimer Notes Relay Therapeutics (RLAY) Pipeline Strength in Mutant-Selective Inhibitors
TheFly reported on January 26 that Oppenheimer upgraded RLAY from Perform to Outperform and set a $14 price target.
20 Best Biotech Stocks Under $20 to Buy Now
The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.
Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608
Relay Therapeutics, Inc.
Top 10 AI-Powered Biotech Stocks to Buy Now
The head biotech analyst at Goldman Sachs, Salveen Richter, made an appearance on CNBC's "Squawk Box" on July 25 to discuss a variety of topics, including the status of the biotech industry and what to...
Hedge Fund Resource Center